Application no. and date | 18732064.3 (espacenet) (Federated) (European Patent Register), 20180618 | Patent/reg. no. and date | DK/EP 3638696, 20240306 | Publication date | 20200422 | Priority no. and date | GB 201709677, 20170616 | EP pub. no. and date |
EP 3638696 20200422 | Effective date | | Applicant/owner | University of Bern, Verwaltungsdirektion Hochschulstrasse 6
3012 Bern, CH, argenx BV, Industriepark-Zwijnaarde 7,
9052 Zwijnaarde (Ghent), BE | Applicant ref. no. | V2404-010-DK | Inventor | LEUPIN, Nicolas, c/o argenx BVBA Industriepark Zwijnaarde 7 Building C
B-9052 Gent, BE, VAN ROMPAEY, Luc, c/o argenx BVBA Industriepark Zwijnaarde 7 Building C
B-9052 Gent, BE, DE HAARD, Hans, c/o argenx BVBA Industriepark Zwijnaarde 7 Building C
B-9052 Gent, BE, OCHSENBEIN, Adrian, Breitenrain 28
3032 Hinterkappelen, CH, RIETHER, Carsten, Gesellschaftsstrasse 44
3012 Bern, CH | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | Title | ANVENDELSE AF ANTI-CD70-ANTISTOF ARGX-110 TIL BEHANDLING AF AKUT MYELOID LEUKÆMI | Int. application no. | EP2018066144 | Int. publication no. | WO2018229303 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|